Testing effectiveness (Phase 2)Looking for participantsNCT06923761
What this trial is testing
EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)
Who this might be right for
Advanced Solid Malignancy
Grey Wolf Therapeutics 300
Showing 20 of 336 results